1887
Volume 2021, Issue 1
  • ISSN: 1999-7086
  • EISSN: 1999-7094

Abstract

: The coronavirus disease 2019 (COVID-19) pandemic has had a massive impact worldwide. Clinical symptoms vary in different countries. In addition, a wide range of symptoms involve most of the body systems including the respiratory system. However, COVID-19 has no classical presenting signs. : This study aimed to describe the sociodemographic and clinical characteristics of hospitalized and nonhospitalized COVID-19 patients in Anbar Governorate, Iraq. : This retrospective study was conducted in Anbar Governorate, Iraq. The study covered the period from May 1 to June 30, 2020. All cases were confirmed by real-time polymerase chain reaction. Data concerning the age, gender, residence, occupation, clinical symptoms, smoking, history of systemic diseases, and disease fate were collected from patients’ records. Of 481 patients, 259 (53.8%) were male. The patient age ranged from 12 to 104 years with a mean age of 45.7 ± 16.11. Majority of the patients aged 36–58 years (n = 204, 42.4%) and were urban dwellers (n = 318, 66.1%), non-healthcare workers (n = 447, 92.9%), and nonsmokers (n = 440, 91.5%). The chief complaint was fever (n = 300, 64.2%). The mortality rate was 5.6% (n = 27). The increasing age, male gender, and a history of systemic illnesses showed an increased effect on the mortality rate ( < 0.05). Residence, occupation, and smoking status did not show significant difference (>0.05). The mortality rate was 5.6%. Fever was the main feature of COVID-19. Male, older individuals with systemic diseases showed higher mortality rate.

Loading

Article metrics loading...

/content/journals/10.5339/jemtac.2021.8
2021-07-12
2021-11-27
Loading full text...

Full text loading...

/deliver/fulltext/jemtac/2021/1/jemtac.2021.8.html?itemId=/content/journals/10.5339/jemtac.2021.8&mimeType=html&fmt=ahah

References

  1. Cascella M, Rajnik M, Aleem A, Dulebohn S, Di Napoli R. Features, evaluation and treatment coronavirus (COVID-19) [Internet]. Statpearls, 2020. Available from: http://www.ncbi.nlm.nih.gov/books/NBK554776/.
    [Google Scholar]
  2. World Health Organization. Global surveillance for COVID-19 disease caused by human infection with the 2019 novel coronavirus (COVID-19): interim guidance, 27 February 2020. [Internet]. WHO; 2020 Feb 27. Available from: https://apps.who.int/iris/handle/10665/331231 .
  3. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323:, 13, 239–1242.
    [Google Scholar]
  4. Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, et al. Clinical characteristics of Covid-19 in New York city. N. Engl. J. Med. 2020; 382:, 24, 2372–2374.
    [Google Scholar]
  5. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395:, 10229, 1054–1062.
    [Google Scholar]
  6. Kolifarhood G, Aghaali M, Saadati HM, Taherpour N, Rahimi S, Izadi N, et al. Epidemiological and clinical aspects of COVID-19; a narrative review. Arch. Acad. Emerg. Med. 2020; 8, 1.
    [Google Scholar]
  7. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020; 382:, 18, 1708–1720.
    [Google Scholar]
  8. Alsofayan YM, Althunayyan SM, Khan AA, Hakawi AM, Assiri AM. Clinical characteristics of COVID-19 in Saudi Arabia: a national retrospective study. J. Infect. Public Health. 2020; 13:, 7, 920–925.
    [Google Scholar]
  9. Channappanavar R, Fett C, Mack M, Ten Eyck. PP, Meyerholz DK, Perlman S. Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection. J. Immunol. 2017; 198:, 10, 4046–4053.
    [Google Scholar]
  10. Badawi A, Ryoo SG. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis. Int. J. Infect. Dis. 2016; 49, 129–133.
    [Google Scholar]
  11. Klein SL, Roberts C. Sex differences in susceptibility to viral infection, in Sex hormones and immunity to infection. Springer. 2010; 93–122.
    [Google Scholar]
  12. Pan L, Mu M, Yang P, Sun Y, Wang R, Yan J, et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am. J. Gastroenterol. 2020; 115:, 5, 766–773.
    [Google Scholar]
  13. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N. Engl. J. Med. 2020; 382:, 13, 1199–1207.
    [Google Scholar]
  14. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395:, 10223, 507–513.
    [Google Scholar]
  15. European Centre for Disease Prevention and Control. Coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK–seventh update [Internet]. Stockholm: ECDC 2020 Mar 25. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/RRA-seventh-update-Outbreak-of-coronavirus-disease-COVID-19.pdf .
  16. Vaira LA, Salzano G, Deiana G, De Riu. G. Anosmia and ageusia: common findings in COVID-19 patients. Laryngoscope. 2020; 130:, 7, 1787–1787.
    [Google Scholar]
  17. Russell B, Moss C, Rigg A, Hopkins C, Papa S, Van Hemelrijck M.. Anosmia and ageusia are emerging as symptoms in patients with COVID-19: what does the current evidence say? Ecancermedicalscience. 2020; 14, ed98.
    [Google Scholar]
  18. Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA. 2020; 323:, 14, 1406–1407.
    [Google Scholar]
  19. Merza MA, Al Mezori. AAH, Mohammed HM, Abdulah DM. COVID-19 outbreak in Iraqi Kurdistan: the first report characterizing epidemiological, clinical, laboratory, and radiological findings of the disease. Diabetes Metab. Syndr. 2020; 14:, 4, 547–554.
    [Google Scholar]
  20. Giacomelli A, Pezzati L, Conti F, Bernacchia D, Siano M, Oreni L, et al. Self-reported olfactory and taste disorders in patients with severe acute respiratory coronavirus 2 infection: a cross-sectional study. Clin. Infect. Dis. 2020; 71:, 15, 889–890.
    [Google Scholar]
  21. World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003 [Internet]. Available from: https://www.who.int/publications/m/item/summary-of-probable-sars-cases-with-onset-of-illness-from-1-november-2002-to-31-july-2003 .
  22. Jiang S, Xia S, Ying T, Lu L. A novel coronavirus (2019-nCoV) causing pneumonia-associated respiratory syndrome. Cell. Mol. Immunol. 2020; 17, 5, 554.
    [Google Scholar]
  23. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020; 323:, 11, 1061–1069.
    [Google Scholar]
  24. Chang D, Lin M, Wei L, Xie L, Zhu G, Cruz CSD, et al. Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China. JAMA. 2020; 323:, 11, 1092–1093.
    [Google Scholar]
  25. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395:, 10223, 497–506.
    [Google Scholar]
  26. Black JR, Bailey C, Przewrocka J, Dijkstra KK, Swanton C. COVID-19: the case for health-care worker screening to prevent hospital transmission. Lancet. 2020; 395:, 10234, 1418–1420.
    [Google Scholar]
  27. Wu C, Chen X, Cai Y, Zhou X, Xu S, Huang H, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern. Med. 2020; 180:, 7, 934–943.
    [Google Scholar]
  28. Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. [The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19)—China, 2020]. Zhonghua Liu Xing Bing Xue Za Zhi [China CDC Weekly]. 2020; 41:(2):145–151.
    [Google Scholar]
  29. Reddy RK, Charles WN, Sklavounos A, Dutt A, Seed PT, Khajuria A. The effect of smoking on COVID-19 severity: a systematic review and meta-analysis. J. Med. Virol. 2021; 93:, 2, 1045–1056.
    [Google Scholar]
  30. Ejaz H, Alsrhani A, Zafar A, Javed H, Junaid K, Abdalla AE, et al. COVID-19 and comorbidities: deleterious impact on infected patients. J. Infect. Public Health. 2020; 13:, 12, 1833–1839.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/jemtac.2021.8
Loading
/content/journals/10.5339/jemtac.2021.8
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error